Keybanc Downgrades Teleflex to Sector Weight
Keybanc analyst Matthew Mishan downgrades Teleflex (NYSE:TFX) from Overweight to Sector Weight.
Teleflex Unveils the UroLift Advanced Tissue Control System and the UroLift 2 System and Real-World Data Presentations at the American Urological Association 2021 Annual Meeting
Teleflex Incorporated (NYSE:TFX) today announced that two new UroLift System products, the UroLift Advanced Tissue Control (ATC) System and the UroLift 2 System, will be launched at the American Urological Association
Keybanc Maintains Overweight on Teleflex, Lowers Price Target to $439
Keybanc analyst Matthew Mishan maintains Teleflex (NYSE:TFX) with a Overweight and lowers the price target from $448 to $439.
SVB Leerink Maintains Market Perform on Teleflex, Raises Price Target to $415
SVB Leerink analyst Richard Newitter maintains Teleflex (NYSE:TFX) with a Market Perform and raises the price target from $410 to $415.
Earnings Scheduled For July 29, 2021
Companies Reporting Before The Bell
• Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.
10 Biggest Price Target Changes For Monday
Goldman Sachs boosted QUALCOMM Incorporated (NASDAQ: QCOM) price target from $136 to $148. QUALCOMM shares rose 0.6% to $140.50 in pre-market trading.
SVB Leerink Downgrades Teleflex to Market Perform, Lowers Price Target to $410
SVB Leerink analyst Richard Newitter downgrades Teleflex (NYSE:TFX) from Outperform to Market Perform and lowers the price target from $485 to $410.